Search results
U.S. FDA places hold on Biomea’s diabetes trial
WHTC 1450 Holland· 3 days ago(Reuters) - Biomea Fusion said on Thursday the U.S. Food and Drug Administration had placed a clinical hold on its ongoing early-to-mid stage study of...
Analysis | Weight-loss drugs are so popular they’re headed for Medicare negotiations
Washington Post· 2 days agoToday’s edition: Conservative policymakers with ties to former president Donald Trump want to limit...
Eli Lilly details NASH effects of weight loss drug (NYSE:LLY)
Seeking Alpha· 4 days agoEli Lilly (LLY) posts detailed mid-stage results highlighting the benefits of its weight loss drug...
Ozempic and Wegovy could soon be challenged by China’s generic competitors
Fast Company Magazine· 3 days agoNovo Nordisk is facing the prospect of intensifying competition in the promising Chinese market...
Structure Therapeutics reports promising weight-loss drug data | Invezz
Invezz· 6 days agoStructure Therapeutics Inc (NASDAQ: GPCR) is up a whopping 80% on Monday after reporting “compelling” topline data for its weight-loss drug. The biopharmaceutical firm said ...
Drug used to treat eczema may provide relief for patients with intensely itchy skin diseases
Medical Xpress· 3 days agoA drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according ...
Dow Jones Futures: Apple AI Push, Tesla, Fed Loom For Stock Market
Investor's Business Daily· 1 hour agoBut there are potentially serious side effects. Eli Lilly stock has boomed over the past year...
The race for a weight loss pill heats up as a Novo Nordisk competitor releases new trial results
Quartz· 6 days agoStructure Therapeutics stock jumped 65% to $56 per share on Monday after the biopharmaceutical...
Retrospective Study Based on Electronic Health Rec | Newswise
Newswise· 6 days agoA new study by researchers at the Case Western Reserve University School of Medicine reveals that...
Eli Lilly hits an all-time high. Wall Street handicaps Monday's key Alzheimer's drug meeting
CNBC· 2 days agoEvery weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20...